Mahindra Finance (B): Finessing business models
Case A (IMD-7-1701) describes the growth trajectory of Mahindra Finance until 2009 when it stumbles with its new product – home loans for the rural market. Case B outlines the steps taken by Mahindra Finance to address the challenges faced by the housing finance business. By incorporating specific changes to the business model in terms of the product, interest rates, repayment schedules and customer acquisition channels, the home loans segment turned around in 2010 and was well set on a growth path. In 2012, Mahindra Finance went on to launch yet another product – finance for small and medium enterprises – with success. By 2015, the company achieved new heights but the key question was how to sustain growth and profitability? A consolidated version of this two-part case is available as Mahindra Finance: Accelerating Growth (IMD-7-1700).
1) Creating an outside-in approach to strategy; (2) Building alternative thinking – to pivot and proceed; (3) Finessing business models.
Mahindra and Mahindra Financial Services, Mahindra and Mahindra, Finance and Insurance, Financial Services
2010–2015
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
The Sandoz leadership team faced an important decision as it broke away from Novartis and became a public company. Should Sandoz retain the global geographical coverage it had had in its many years as part of Novartis? Or should it focus on fewer ...
This case series explores Sandoz's spin off from Novartis, which was finalized on 4 October 2023. Case A follows Richard Saynor's (CEO, Sandoz) ruminations as he builds the company strategy in preparation for the board's approval of Sandoz as a st...
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-2669 ©2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD Brain Circuits 4 September 2025
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications